Form 8-K - Current report:
SEC Accession No. 0001193125-19-306821
Filing Date
2019-12-05
Accepted
2019-12-05 08:31:16
Documents
44
Period of Report
2019-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816321d8k.htm 8-K 18026
2 EX-99.1 d816321dex991.htm EX-99.1 46781
3 GRAPHIC g816321ex99_1s10g1.jpg GRAPHIC 296816
4 GRAPHIC g816321ex99_1s11g1.jpg GRAPHIC 339244
5 GRAPHIC g816321ex99_1s12g1.jpg GRAPHIC 285484
6 GRAPHIC g816321ex99_1s13g1.jpg GRAPHIC 282452
7 GRAPHIC g816321ex99_1s14g1.jpg GRAPHIC 330007
8 GRAPHIC g816321ex99_1s15g1.jpg GRAPHIC 292427
9 GRAPHIC g816321ex99_1s16g1.jpg GRAPHIC 310716
10 GRAPHIC g816321ex99_1s17g1.jpg GRAPHIC 301954
11 GRAPHIC g816321ex99_1s18g1.jpg GRAPHIC 322289
12 GRAPHIC g816321ex99_1s19g1.jpg GRAPHIC 315846
13 GRAPHIC g816321ex99_1s1g1.jpg GRAPHIC 213990
14 GRAPHIC g816321ex99_1s20g1.jpg GRAPHIC 258969
15 GRAPHIC g816321ex99_1s21g1.jpg GRAPHIC 251153
16 GRAPHIC g816321ex99_1s22g1.jpg GRAPHIC 260054
17 GRAPHIC g816321ex99_1s23g1.jpg GRAPHIC 320790
18 GRAPHIC g816321ex99_1s24g1.jpg GRAPHIC 351195
19 GRAPHIC g816321ex99_1s25g1.jpg GRAPHIC 357390
20 GRAPHIC g816321ex99_1s26g1.jpg GRAPHIC 230158
21 GRAPHIC g816321ex99_1s27g1.jpg GRAPHIC 237869
22 GRAPHIC g816321ex99_1s28g1.jpg GRAPHIC 310854
23 GRAPHIC g816321ex99_1s29g1.jpg GRAPHIC 244964
24 GRAPHIC g816321ex99_1s2g1.jpg GRAPHIC 494925
25 GRAPHIC g816321ex99_1s30g1.jpg GRAPHIC 287023
26 GRAPHIC g816321ex99_1s31g1.jpg GRAPHIC 247035
27 GRAPHIC g816321ex99_1s32g1.jpg GRAPHIC 317882
28 GRAPHIC g816321ex99_1s33g1.jpg GRAPHIC 293996
29 GRAPHIC g816321ex99_1s34g1.jpg GRAPHIC 265280
30 GRAPHIC g816321ex99_1s35g1.jpg GRAPHIC 201960
31 GRAPHIC g816321ex99_1s36g1.jpg GRAPHIC 314320
32 GRAPHIC g816321ex99_1s37g1.jpg GRAPHIC 279016
33 GRAPHIC g816321ex99_1s38g1.jpg GRAPHIC 322109
34 GRAPHIC g816321ex99_1s39g1.jpg GRAPHIC 256671
35 GRAPHIC g816321ex99_1s3g1.jpg GRAPHIC 292697
36 GRAPHIC g816321ex99_1s40g1.jpg GRAPHIC 273309
37 GRAPHIC g816321ex99_1s41g1.jpg GRAPHIC 329953
38 GRAPHIC g816321ex99_1s42g1.jpg GRAPHIC 235215
39 GRAPHIC g816321ex99_1s4g1.jpg GRAPHIC 355399
40 GRAPHIC g816321ex99_1s5g1.jpg GRAPHIC 284346
41 GRAPHIC g816321ex99_1s6g1.jpg GRAPHIC 297237
42 GRAPHIC g816321ex99_1s7g1.jpg GRAPHIC 355478
43 GRAPHIC g816321ex99_1s8g1.jpg GRAPHIC 294743
44 GRAPHIC g816321ex99_1s9g1.jpg GRAPHIC 265696
  Complete submission text file 0001193125-19-306821.txt   17121131
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 191269513
SIC: 2834 Pharmaceutical Preparations